These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 17099794)

  • 21. Treatment of vancomycin-resistant Enterococcus faecium infections.
    Lai KK
    Arch Intern Med; 1996 Dec 9-23; 156(22):2579-84. PubMed ID: 8951301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the MicroScan system and the agar dilution assay for Quinupristin/Dalfopristin susceptibility of Enterococcus faecium.
    Kim YR; Kim SI; Hur JA; Kim YJ; Wie SH; Park YJ; Kang MW
    Ann Clin Lab Sci; 2007; 37(3):260-2. PubMed ID: 17709691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
    Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
    Wareham DW; Abbas H; Karcher AM; Das SS
    J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aminoglycoside resistant enterococcal endocarditis.
    Eliopoulos GM
    Infect Dis Clin North Am; 1993 Mar; 7(1):117-33. PubMed ID: 8463648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens.
    McDonald LC; Rossiter S; Mackinson C; Wang YY; Johnson S; Sullivan M; Sokolow R; DeBess E; Gilbert L; Benson JA; Hill B; Angulo FJ
    N Engl J Med; 2001 Oct; 345(16):1155-60. PubMed ID: 11642231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotype.
    Song JH; Ko KS; Suh JY; Oh WS; Kang CI; Chung DR; Peck KR; Lee NY; Lee WG
    J Antimicrob Chemother; 2008 Apr; 61(4):838-44. PubMed ID: 18230690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
    Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E
    Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of life-threatening multiresistant staphylococcal and enterococcal infections in patients with end-stage renal failure with quinupristin/dalfopristin: preliminary report.
    Schwenger V; Mündlein E; Dagrosa EE; Fahr AM; Zeier M; Mikus G; Andrassy K
    Infection; 2002 Oct; 30(5):257-61. PubMed ID: 12382082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin.
    Linden PK; Moellering RC; Wood CA; Rehm SJ; Flaherty J; Bompart F; Talbot GH;
    Clin Infect Dis; 2001 Dec; 33(11):1816-23. PubMed ID: 11668430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activities of cefotaxime, vancomycin, quinupristin/dalfopristin, linezolid and other antibiotics alone and in combination against Propionibacterium acnes isolates from central nervous system infections.
    Mory F; Fougnot S; Rabaud C; Schuhmacher H; Lozniewski A
    J Antimicrob Chemother; 2005 Feb; 55(2):265-8. PubMed ID: 15590714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative in vitro activity of quinupristin/dalfopristin against multidrug resistant Enterococcus faecium.
    Bonilla HF; Perri MB; Kauffman CA; Zervos MJ
    Diagn Microbiol Infect Dis; 1996 Jul; 25(3):127-31. PubMed ID: 8902408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of tigecycline alone and in combination with gentamicin in the treatment of experimental endocarditis due to linezolid-resistant Enterococcus faecium.
    Pontikis K; Pefanis A; Tsaganos T; Tzepi IM; Carrer DP; Giamarellou H
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3392-4. PubMed ID: 23587961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vancomycin-resistant Enterococcus faecium infections in the ICU and quinupristin/dalfopristin.
    Zervos M
    New Horiz; 1996 Aug; 4(3):385-92. PubMed ID: 8856757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vancomycin-resistant Enterococcus faecium meningitis in adults: case series and review of the literature.
    Knoll BM; Hellmann M; Kotton CN
    Scand J Infect Dis; 2013 Feb; 45(2):131-9. PubMed ID: 22992165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.
    Babcock HM; Ritchie DJ; Christiansen E; Starlin R; Little R; Stanley S
    Clin Infect Dis; 2001 May; 32(9):1373-5. PubMed ID: 11303275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis.
    Fantin B; Leclercq R; Garry L; Carbon C
    Antimicrob Agents Chemother; 1997 May; 41(5):931-5. PubMed ID: 9145847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis.
    Patel R; Rouse MS; Piper KE; Steckelberg JM
    Antimicrob Agents Chemother; 2001 Feb; 45(2):621-3. PubMed ID: 11158767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].
    Apellaniz G; Valdés M; Pérez R; Martín-Luengo F; García A; Soria F; Gómez J
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):208-10. PubMed ID: 1830757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.